Drug Database
Back to search

Poland· PL-100247921

Willfact 1000 j.m.

A von willebrand factor product containing factor humanus von willebrandi, registered in Poland by LFB-Biomedicaments. The same ATC class is registered in 11 of our 19 countries.

ATC B02BD10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedWillfact 1000 j.m.ATCB02BD10REGISTER NO.PL-100247921PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about factor humanus von willebrandiAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Von willebrand factor is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD10 (von willebrand factor), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search von willebrand factor products by name

Von willebrand factor · ATC B02BD10

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Factor humanus von Willebrandi
Manufacturer
LFB-Biomedicaments
Country
Poland (PL)
ATC code
B02BD10
ATC class
Von Willebrand factor
Defined daily dose
1.5 TSD, E
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990866540

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for von willebrand factor.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check von willebrand factor against other medicinesHow interaction checks work

Von willebrand factor · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Von willebrand factor in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All von willebrand factor products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Willfact
  • Belgium · Wilfactin
  • Czechia · Willfact
  • Germany · Willfact
  • Denmark · Willfact
  • Spain · Willfact
  • Finland · Haemate, Wilfactin
  • France · Wilfactin
  • United Kingdom (Northern Ireland) · Willfact
  • Greece · Haemate P, Wilfactin
  • Italy · Wilfactin
  • Netherlands · Wilfactin
  • Norway · Willfact
  • Sweden · Willfact
  • Slovakia · Willfact

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0de316f5-c13e-45a0-b62a-097cf2e55c9d
GET /v1/drugs/0de316f5-c13e-45a0-b62a-097cf2e55c9d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "1000 j.m.",
  "packaging": "05909990866540 ¦ Lz ¦ 66346\n1 fiol.  proszku + fiol. rozp. + zestaw do rekonstytucji",
  "substance": "Factor humanus von Willebrandi 1000 j.m.",
  "common_name": "Factor humanus von Willebrandi",
  "pl_product_id": "100247921",
  "pozwolenie_nr": "18351",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about von willebrand factor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console